MDGL logo

Madrigal Pharmaceuticals, Inc. (MDGL) Debt To Equity Ratio

Annual Debt To Equity:

0.16-0.13(-44.83%)
December 31, 2024

Summary

  • As of today, MDGL annual debt to equity ratio is 0.16, with the most recent change of -0.13 (-44.83%) on December 31, 2024.
  • During the last 3 years, MDGL annual debt to equity has risen by +0.16 (+100.00%).
  • MDGL annual debt to equity is now -85.84% below its all-time high of 1.13, reached on December 31, 2011.

Performance

MDGL Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLfinancial health metrics

Quarterly Debt To Equity:

0.18+0.01(+5.88%)
June 30, 2025

Summary

  • As of today, MDGL quarterly debt to equity ratio is 0.18, with the most recent change of +0.01 (+5.88%) on June 30, 2025.
  • Over the past year, MDGL quarterly debt to equity has increased by +0.04 (+28.57%).
  • MDGL quarterly debt to equity is now -96.56% below its all-time high of 5.24, reached on September 30, 2023.

Performance

MDGL Quarterly Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLfinancial health metrics

Debt To Equity Formula

Debt To Equity =  
Total Debt
Shareholders Equity

MDGL Debt To Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-44.8%+28.6%
3Y3 Years+100.0%-70.0%
5Y5 Years+100.0%+100.0%

MDGL Debt To Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-44.8%>+9999.0%-96.6%+28.6%
5Y5-Year-44.8%>+9999.0%-96.6%>+9999.0%
All-TimeAll-Time-85.8%+116.0%-96.6%+105.7%

MDGL Debt To Equity History

DateAnnualQuarterly
Jun 2025
-
0.18(+5.9%)
Mar 2025
-
0.17(+6.3%)
Dec 2024
0.16(-44.8%)
0.16(+6.7%)
Sep 2024
-
0.15(+7.1%)
Jun 2024
-
0.14(0.0%)
Mar 2024
-
0.14(-51.7%)
Dec 2023
0.29(+16.0%)
0.29(-94.5%)
Sep 2023
-
5.24(+445.8%)
Jun 2023
-
0.96(+71.4%)
Mar 2023
-
0.56(+124.0%)
Dec 2022
0.25(>+9900.0%)
0.25(-94.6%)
Sep 2022
-
4.67(+678.3%)
Jun 2022
-
0.60(>+9900.0%)
Mar 2022
-
0.00(0.0%)
Dec 2021
0.00(0.0%)
0.00(0.0%)
Sep 2021
-
0.00(0.0%)
Jun 2021
-
0.00(0.0%)
Mar 2021
-
0.00(0.0%)
Dec 2020
0.00(0.0%)
0.00(0.0%)
Sep 2020
-
0.00(0.0%)
Jun 2020
-
0.00(0.0%)
Mar 2020
-
0.00(0.0%)
Dec 2019
0.00(0.0%)
0.00(0.0%)
Sep 2019
-
0.00(0.0%)
Jun 2019
-
0.00(0.0%)
Mar 2019
-
0.00(0.0%)
Dec 2018
0.00(0.0%)
0.00(0.0%)
Sep 2018
-
0.00(0.0%)
Jun 2018
-
0.00(0.0%)
Mar 2018
-
0.00(0.0%)
Dec 2017
0.00(0.0%)
0.00(0.0%)
Sep 2017
-
0.00(0.0%)
Jun 2017
-
0.00(0.0%)
Mar 2017
-
0.00(0.0%)
Dec 2016
0.00(+100.0%)
0.00(0.0%)
Sep 2016
-
0.00(0.0%)
Jun 2016
-
0.00(-100.0%)
Mar 2016
-
0.05(+105.1%)
Dec 2015
-1.00
-0.99(-925.0%)
Sep 2015
-
0.12(-7.7%)
Jun 2015
-
0.13(-48.0%)
DateAnnualQuarterly
Mar 2015
-
0.25(+19.0%)
Dec 2014
0.21(-56.3%)
0.21(+10.5%)
Sep 2014
-
0.19(-24.0%)
Jun 2014
-
0.25(-54.5%)
Mar 2014
-
0.55(+14.6%)
Dec 2013
0.48(+182.4%)
0.48(-70.2%)
Sep 2013
-
1.61(+140.3%)
Jun 2013
-
0.67(+59.5%)
Mar 2013
-
0.42(+147.1%)
Dec 2012
0.17(-85.0%)
0.17(-62.2%)
Sep 2012
-
0.45(-43.8%)
Jun 2012
-
0.80(+63.3%)
Mar 2012
-
0.49(-56.6%)
Dec 2011
1.13(+73.8%)
1.13(+66.2%)
Sep 2011
-
0.68(+44.7%)
Jun 2011
-
0.47(-64.1%)
Mar 2011
-
1.31(+101.5%)
Dec 2010
0.65(+712.5%)
0.65(+12.1%)
Sep 2010
-
0.58(+1350.0%)
Jun 2010
-
0.04(0.0%)
Mar 2010
-
0.04(-50.0%)
Dec 2009
0.08(+214.3%)
0.08(0.0%)
Sep 2009
-
0.08(+366.7%)
Jun 2009
-
-0.03(+25.0%)
Mar 2009
-
-0.04(+42.9%)
Dec 2008
-0.07(-133.3%)
-0.07(+50.0%)
Sep 2008
-
-0.14(+73.6%)
Jun 2008
-
-0.53(-215.2%)
Mar 2008
-
0.46(+119.0%)
Dec 2007
0.21(+50.0%)
0.21(+50.0%)
Sep 2007
-
0.14(+27.3%)
Jun 2007
-
0.11(+37.5%)
Mar 2007
-
0.08(+102.5%)
Dec 2006
0.14(+16.7%)
-3.15(-2963.6%)
Sep 2006
-
0.11(+175.0%)
Dec 2005
0.12(+1100.0%)
0.04(+300.0%)
Mar 2005
-
0.01
Dec 2004
0.01(>+9900.0%)
-
Dec 2003
0.00(0.0%)
-
Dec 2002
0.00(0.0%)
-
Dec 2001
0.00
-

FAQ

  • What is Madrigal Pharmaceuticals, Inc. annual debt to equity ratio?
  • What is the all-time high annual debt to equity for Madrigal Pharmaceuticals, Inc.?
  • What is Madrigal Pharmaceuticals, Inc. annual debt to equity year-on-year change?
  • What is Madrigal Pharmaceuticals, Inc. quarterly debt to equity ratio?
  • What is the all-time high quarterly debt to equity for Madrigal Pharmaceuticals, Inc.?
  • What is Madrigal Pharmaceuticals, Inc. quarterly debt to equity year-on-year change?

What is Madrigal Pharmaceuticals, Inc. annual debt to equity ratio?

The current annual debt to equity of MDGL is 0.16

What is the all-time high annual debt to equity for Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. all-time high annual debt to equity ratio is 1.13

What is Madrigal Pharmaceuticals, Inc. annual debt to equity year-on-year change?

Over the past year, MDGL annual debt to equity ratio has changed by -0.13 (-44.83%)

What is Madrigal Pharmaceuticals, Inc. quarterly debt to equity ratio?

The current quarterly debt to equity of MDGL is 0.18

What is the all-time high quarterly debt to equity for Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. all-time high quarterly debt to equity ratio is 5.24

What is Madrigal Pharmaceuticals, Inc. quarterly debt to equity year-on-year change?

Over the past year, MDGL quarterly debt to equity ratio has changed by +0.04 (+28.57%)
On this page